<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Biotherapy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Biotherapy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский биотерапевтический журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9784</issn><issn publication-format="electronic">1726-9792</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">880</article-id><article-id pub-id-type="doi">10.17650/1726-9784-2017-16-3-59-62</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL REPORTS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Detection of human papillomavirus type 16 oncogen E7 in surgical materials from Russian prostate cancer patients</article-title><trans-title-group xml:lang="ru"><trans-title>Обнаружение онкогена Е7 вируса папилломы человека 16-го типа в операционном материале от российских больных раком предстательной железы</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Volgareva</surname><given-names>G. M.</given-names></name><name xml:lang="ru"><surname>Волгарева</surname><given-names>Г. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>galina.volgareva@ronc.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ermilova</surname><given-names>V. D.</given-names></name><name xml:lang="ru"><surname>Ермилова</surname><given-names>В. Д.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khachaturyan</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Хачатурян</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Tatarskiy</surname><given-names>V. V.</given-names></name><name xml:lang="ru"><surname>Татарский</surname><given-names>В. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pavlova</surname><given-names>L. S.</given-names></name><name xml:lang="ru"><surname>Павлова</surname><given-names>Л. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin Russian Cancer Research Center, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ«НМИЦ онкологии им. Н.Н. Блохина» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-09-30" publication-format="electronic"><day>30</day><month>09</month><year>2017</year></pub-date><volume>16</volume><issue>3</issue><fpage>59</fpage><lpage>62</lpage><history><date date-type="received" iso-8601-date="2018-04-10"><day>10</day><month>04</month><year>2018</year></date></history><permissions/><self-uri xlink:href="https://bioterapevt.abvpress.ru/jour/article/view/880">https://bioterapevt.abvpress.ru/jour/article/view/880</self-uri><abstract xml:lang="en"><p>Introduction. High indices of prostate cancer (PC) incidence and mortality as well as high speed of growth of these figures testify to urgency of research into PC origin as well as means of its prophylaxis. The problem of possible PC association with oncogenic human papillomaviruses (HPV) is still being disputable. Objective: to test whether surgical materials from PC patients in Russia harbour E7 oncogene of HPV type 16 (HPV16), the main HPV type responsible for cervical cancer. Materials and methods. Prostate tissues excised in the course of radical prostatectomy from 17 PC patients were tested by polymerase chain reaction. For better DNA preservation cryopreserved tumor specimens not treated with either formalin or paraffin were used. The PC typical multifocal type of growth was taken into account by microdissecting of cryostate cuts to accumulate homogeneous cells (cancerous, dysplastic or normal). Results. HPV16 E7 was registered in prostate tissues of 7 patients out of 17 examined including all those 5 cases for which DNA had been isolated from homogeneous sites of cancer cells. Conclusion. The result obtained enables one to admit that HPV16 may be harbored in prostates of Russian PC patients not infrequently.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="ru"><kwd>предстательная железа</kwd><kwd>рак</kwd><kwd>вирусы папилломы человека</kwd><kwd>профилактика</kwd><kwd>prostate</kwd><kwd>cancer</kwd><kwd>human papillomaviruses</kwd><kwd>prophylaxis</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Torre L.A., Siegel R.L., Ward E.M., Jemal A. Global cancer incidence and mortality rates and trends - an update. Cancer Epidemiol Biomarkers Prev 2016;25(1):16-27. DOI: 10.1158/1055-9965.EPI-15-0578. PMID: 26667886.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002;2(5):342-50. DOI: 10.1038/nrc798. PMID: 12044010.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>zur Hausen H. Papillomaviruses - to vaccination and beyond. Biochemistry (Mosc) 2008;73(5):498-503. PMID: 18605974.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Guo Z., Wu F., Asplund A. et al. Analysis of intratumoral heterogeneity of chromosome 3p deletions and genetic evidence of polyclonal origin of cervical squamous carcinoma. Mod Pathol 2001;14(2):54-61. DOI: 10.1038/modpathol.3880256. PMID: 11235906.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Smelov V., Eklund C., Bzhalava D. et al. Expressed prostate secretions in the study of human papillomavirus epidemiology in the male. PLOS One 2013;8(6):e66630. DOI: 10/1371/journal.pone.0066630. PMID: 23799125.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Ragin C., Obikoya-Malomo M., Kim S. et al. HPV-associated lung cancers: an international pooled analysis. Carcinogenesis 2014;35(6):1267-75. DOI: 10.1093/carcin/bgu038. PMID: 24523449.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>de Villiers E.M., Sandstrom R.E., zur Hausen H., Buck C.E. Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res 2005;7(1):R1 -11. DOI: 10.1186/bcr940.</mixed-citation></ref></ref-list></back></article>
